PK MED
Created in 2019
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
694Activities
Technologies
Entity types
Location
14 Rue Jean Antoine de Baïf, 75013 Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 10
Engaged corporates
5
1 4Added in Motherbase
5 months, 1 week ago
deeptech Value proposition
Tailor-designed drug implants for local treatments.
Founded by Truffle Capital.
PK MED is a pioneering French biotech company, privately owned and founded in 2019 in Lyon, France, with the backing of Truffle Capital, a leading European venture capital firm specializing in life sciences.
Built around a dedicated team of passionate and seasoned experts in pharmaceutical sciences, drug delivery, and biomaterials design, PK MED combines innovation and expertise to develop cutting-edge solutions in healthcare.
PK MED specializes in the development of innovative, custom-designed, injectable, and biodegradable micro-implants, leveraging its expertise to address critical healthcare challenges. Our focus lies in advanced drug delivery systems for rheumatology and pioneering cell-homing techniques to enhance the success of bone marrow transplantation.
Driven by a commitment to unmet medical needs, PK MED has built a promising portfolio of early-stage projects targeting key therapeutic areas, including gout flares, osteoarthritis, and hemoglobinopathies
Drug Delivery, Drug reformulation, Drug repurposing, Biomaterials, Pharmaceuticals, Biotechnology, BioTech, Innovation, and Sustained ReleaseOriginal language
Tailor-designed drug implants for local treatments.
Founded by Truffle Capital.
PK MED is a pioneering French biotech company, privately owned and founded in 2019 in Lyon, France, with the backing of Truffle Capital, a leading European venture capital firm specializing in life sciences.
Built around a dedicated team of passionate and seasoned experts in pharmaceutical sciences, drug delivery, and biomaterials design, PK MED combines innovation and expertise to develop cutting-edge solutions in healthcare.
PK MED specializes in the development of innovative, custom-designed, injectable, and biodegradable micro-implants, leveraging its expertise to address critical healthcare challenges. Our focus lies in advanced drug delivery systems for rheumatology and pioneering cell-homing techniques to enhance the success of bone marrow transplantation.
Driven by a commitment to unmet medical needs, PK MED has built a promising portfolio of early-stage projects targeting key therapeutic areas, including gout flares, osteoarthritis, and hemoglobinopathies
PK MED | Treatment in gout flares
PK MED has developed a portfolio of early projects in indications with high unmet medical needs, starting with Gout flare (PKM-01), Osteoarthritis (PKM-011) and Hemoglobinopathies (PKM-02).
https://www.pk-med.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Auvergne-Rhone-Alpes Entreprises - Isère National and local authorities, Business Consulting and Services | Auvergne-Rhone-Alpes Entreprises - Isère National and local authorities, Business Consulting and Services | Other 27 Sep 2024 | | |
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 31 Jan 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 31 Jan 2024 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 16 Nov 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 23 Jul 2024 | | |